Literature DB >> 11599812

Peritonitis associated with Actinobacillus equuli in horses: 51 cases.

S Matthews1, A J Dart, B A Dowling, J L Hodgson, D R Hodgson.   

Abstract

OBJECTIVE: To review the clinical findings, diagnosis and treatment of 51 horses with peritonitis attributed to Actinobacillus equuli.
DESIGN: Retrospective study of clinical cases.
METHODS: Breed, age and gender of horse, history, physical examination findings, treatment and outcome were determined from the hospital records of 51 horses in which a diagnosis of peritonitis attributed to A. equuli was made between January 1993 and June 1999. Results of abdominal fluid cytology and bacteriology, antimicrobial sensitivity patterns, haematology and faecal egg counts, when performed, were also retrieved.
RESULTS: There was a variety of breeds of horses affected. There were 35 male and 17 female horses, aged from 9 months to 22 years, presented. Lethargy, signs of depression with mild to moderate signs of abdominal pain and inappetence were the most common reasons for presentation. Most horses had elevated heart and respiratory rates, an elevated rectal temperature and reduced intestinal borborygmi heard on auscultation of the abdomen. Abnormal colour with an elevated protein were features of an abdominal fluid sample in 98% of horses and a marked elevation in nucleated cell count was present in all samples. Pleomorphic gram-negative rods were seen on cytology in 53% of samples and a positive culture of A. equuli was returned in 72% of samples. Other laboratory findings in some horses included mild haemoconcentration, hypoproteinaemia, an elevated circulating nucleated cell count with a left shift, an elevation in fibrinogen concentration and an elevated faecal egg count. All horses demonstrated a rapid response to treatment with procaine penicillin alone, or a combination of procaine penicillin and gentamicin sulphate. Where antimicrobial sensitivity tests were performed, all but two isolates were sensitive to procaine penicillin. All horses responded to antimicrobial and supportive therapy and were discharged from hospital.
CONCLUSION: Horses with A. equuli peritonitis present with similar clinical signs as horses with other causes of abdominal pain. However, these signs, when evaluated in conjunction with the results of abdominal fluid analysis and response to treatment, are characteristic of A. equuli peritonitis. Pleomorphic gram-negative bacteria may be seen on a cytological preparation of the abdominal fluid sample, and a positive bacterial culture may be obtained in some, but not all, cases. Most isolates are sensitive to procaine penicillin, so treatment with procaine penicillin and gentamicin sulphate is recommended until antimicrobial sensitivity is known.

Entities:  

Mesh:

Year:  2001        PMID: 11599812     DOI: 10.1111/j.1751-0813.2001.tb10741.x

Source DB:  PubMed          Journal:  Aust Vet J        ISSN: 0005-0423            Impact factor:   1.281


  4 in total

1.  Reactive mesothelial hyperplasia associated with chronic peritonitis in a 20-year-old Quarter horse.

Authors:  Laura L Hoon-Hanks; Emily D Rout; Linda M Vap; Tawfik A Aboellail; Diana M Hassel; Yvette S Nout-Lomas
Journal:  Can Vet J       Date:  2016-05       Impact factor: 1.008

2.  Complete genome sequence of Actinobacillus equuli subspecies equuli ATCC 19392(T).

Authors:  Barbara F Huang; Andrew M Kropinski; Adina R Bujold; Janet I MacInnes
Journal:  Stand Genomic Sci       Date:  2015-06-07

3.  Parasite Occurrence and Parasite Management in Swedish Horses Presenting with Gastrointestinal Disease-A Case-Control Study.

Authors:  Ylva Hedberg-Alm; Johanna Penell; Miia Riihimäki; Eva Osterman-Lind; Martin K Nielsen; Eva Tydén
Journal:  Animals (Basel)       Date:  2020-04-07       Impact factor: 2.752

4.  Clinical features and treatment response to differentiate idiopathic peritonitis from non-strangulating intestinal infarction of the pelvic flexure associated with Strongylus vulgaris infection in the horse.

Authors:  Ylva Hedberg-Alm; Eva Tydén; Lena-Mari Tamminen; Lisa Lindström; Karin Anlén; Maria Svensson; Miia Riihimäki
Journal:  BMC Vet Res       Date:  2022-04-23       Impact factor: 2.792

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.